Goldman Sachs Group »

Astria Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Astria Therapeutics (ATXS) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $3.0M 214k 14.08
2023-12-31 $126k 16k 7.68
2023-09-30 $213k 29k 7.46
2023-06-30 $214k 26k 8.33
2023-03-31 $960k 72k 13.30
2021-09-30 $99k 11k 8.82